Building your clientele base is an important part of making sure your business will grow. Repeat customers are important and you should continue to maintain good relationships with your existing customers. But, it is also necessary to reach more people, so you can gain more clientele. These are some quick and easy ways you can use social media to your advantage. https://youtu.be/r45W-dyXI1U
Today, Cox Enterprises released the results of the second annual Cox Conserves Sustainability Survey, which showcased that Millennials will lead the way for small and medium businesses in future conversations and efforts around conservation, energy efficiency and environmental stewardship. The survey, commissioned by Cox Enterprises, is a national study that examines sustainability opportunities and challenges for small and medium-sized businesses (SMBs).
The top finding from the 2015 survey is that Millennials have a huge appetite for sustainability and will drive adoption of these practices. Millennials showed greater knowledge about sustainability than other age cohorts and a strong interest in implementing sustainable business practices, but noted that in their current roles, they lacked the influence needed to effect change.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7486651-cox-conserves-sustainability-survey/
The 1-year Full-Time MBA is the School’s flagship program with just about 100 MBA students. It is a challenging life time experience to learn the art of management and grow personally and professionally.
Full-Time MBA structure is organized around three cornerstones: Planning and Innovating, Controlling and Investing, Leading People and Processes. These core courses represent the competence requirements of a global manager.
To view the Multimedia News Release, go to http://www.multivu.com/players/uk/7674251-sda-bocconi-1-year-full-time-mba/
http://adanimations.com/free-graphics-set/
Free video animation loops. Simply go to our website and subscribe to
receive this and many more excited video animations you can use for
your explainer videos, online marketing, affiliate marketing, and much
more! These animations are brand new, never before published!
Today Barclaycard US, the payments business of Barclays in the United States, announced the launch of the #IHAVEARRIVED Travel Community contest, hosted by Barclaycard Arrival™ MasterCard®. Travel enthusiasts and Barclaycard Arrival cardmembers are invited to join the Barclaycard Travel Community to share their #IHAVEARRIVED travel moment. Barclaycard Arrival cardmembers who enter, have the opportunity to win an exclusive grand prize trip for two to the 58th Annual GRAMMY Awards® in February 2016. Community members who are not Barclaycard Arrival cardmembers have an opportunity to choose between two grand prize options: a West Coast VIP trip for two to Napa Valley, California or an East Coast VIP trip for two to New York City.
“Since launching in 2013, Barclaycard Arrival continues to be recognized by industry experts as the go-to travel card,” said Maurice Ragland, vice president of branded cards. “We make it easy for cardmembers to have once-in-a-lifetime adventures by offering the industry’s best travel rewards program. What better way to showcase these moments than through the #IHAVEARRIVED campaign.”
Travel enthusiasts across the country are encouraged to share memorable travel stories from October 28 through November 22 in the Barclaycard Travel Community. Entries must include a short description and photo of the travel experience. Entries will be judged on originality, creativity, writing and photography.
To view the multimedia release go to:
http://www.multivu.com/players/English/7671251-barclaycard-ihavearrived-launch/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Description: http://epicecommercetools.com/2015/02/11/creating-concrete-community-connections/ Quick tips on best practices for connecting you’re your business community. Having a solid relationship with your team, customers, and partners is an integral part to achieving better customer relationships. One of the best ways to ensure these connections is to be open to constructive criticism. Another way is to be honest with your customers, customers like it when you are open to talking about your company. Here are some great tips on how feedback can make your business relationships better.
The Egyptian Ministry of Antiquities is pleased to announce the launch of an egyptian – international Project using non-invasive and non-destructive surveying techniques for the scanning of Egyptian Pyramids under the title “ScanPyramids” project.
Just because a mystery is 4500 years old doesn’t mean it can’t be solved…” This could be the motto of the exceptional scientific mission launched October 25, 2015, under the authority of the Egyptian Ministry of Antiquities, initiated, designed and coordinated by the Faculty of Engineering of Cairo and the French HIP.Institute (Heritage, Innovation and Preservation). Radiographic muons, aka cosmic particles, infrared thermography, photogrammetry, scanner and 3D reconstruction: the most innovative technologies will be used by researchers of international renown and three major universities: the Faculty of Engineering of Cairo University, Université Laval of Quebec and Nagoya University of Japan. Their goal: to probe the heart of the largest pyramids of Egypt, without drilling the slightest opening.
Four millennia after their construction, these ancient giants are far from having yielded their secrets. The first mystery concerns their construction, especially Khufu, the last of the Seven Wonders of the Ancient World still existing: it is still impossible to describe with certainty how this stone monument, the largest ever built by humans, was erected.
The “ScanPyramids” project has already been approved by the permanent committee of the Ministry of Antiquities and has obtained all necessary permissions from concerned authorities. With a base of more than 5 hectares, its original height of almost 150 meters and a mass of 5 million tons, how was it possible to construct such a wonder in only 25 years?
To view the multimedia release go to:
http://www.multivu.com/players/uk/7671551-scanpyramids-project-launch-egyptian/
When a serious illness enters a family's life, there are many questions to ask and decisions to make. It is important to answer these questions quickly. The process can seem overwhelming. However, hospice care can be a wonderful resource for information about symptom management and comfort care. Hospice care professionals are available to help assess goals, pain management and care options during the decision-making process.
Are your symptoms minimal or moderate? Are these symptoms just starting to affect your life? If you want to continue treatment but also need comfort and symptom management, palliative care (often called comfort care) maybe an option. Palliative care is patient and family-centered care that optimizes quality of life by anticipating, preventing and treating suffering. Palliative care specialists address the physical, intellectual, emotional, social, and spiritual needs of patients and families, making sure they have access to all the information about the disease progression and the choices ahead. A patient can receive palliative care in conjunction with other treatments or therapies.
To view the multimedia release go to:
http://www.multivu.com/players/English/7429131-moments-of-life-by-hospice/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
